Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Surgery, Weill Cornell Medicine and New York-Presbyterian, New York, NY, USA.
Ann Surg Oncol. 2023 Jan;30(1):115-121. doi: 10.1245/s10434-022-12560-7. Epub 2022 Sep 23.
Patients with clinical T4M0 breast cancer are recommended to undergo neoadjuvant chemotherapy, modified radical mastectomy, and postmastectomy radiotherapy. This study determined whether BREAST-Q scores differ by decision to pursue reconstruction or timing of reconstruction.
This retrospective, single-institutional study analyzed cT4 breast cancer patients from 2014 to 2021 without evidence of distant metastatic disease undergoing mastectomy with or without reconstruction. As routine care, BREAST-Q was administered preoperatively, then 6 months, 1 year, and 2 years postoperatively. Satisfaction and quality-of-life domains were compared between mastectomy with no reconstruction (NR), immediate reconstruction (IR), and delayed reconstruction (DR) groups.
Of the 144 patients eligible for this study, 71 (49%) had NR, 36 (25%) had DR, and 37 (26%) had IR. The patients undergoing reconstruction were younger and more likely to elect contralateral prophylactic mastectomy. Timing of reconstruction was not associated with significant differences in satisfaction with breasts (SATBR) at any time point. For the patients who had DR, breast satisfaction increased over time after reconstructive surgery. Physical well-being of the chest (PWB-CHEST) did not significantly differ among IR, DR, and NR at any time point. The patients who underwent DR experienced improvement in PWB-CHEST scores from preoperative scores. The patients with IR and NR experienced PWB-CHEST decline over time. Psychosocial well-being (PSWB) did not differ significantly across time or by subgroup.
The patients with T4 breast cancer who elected reconstruction did not differ in patient-reported outcomes based on timing of reconstruction. In the DR cohort, SATBR significantly improved after reconstructive surgery. These data can help inform breast reconstructive decision-making for patients facing the choice among DR, IR, and NR.
临床 T4M0 乳腺癌患者建议行新辅助化疗、改良根治性乳房切除术和乳房切除术后放疗。本研究旨在确定是否根据重建的决策或重建的时间来改变 BREAST-Q 评分。
这是一项回顾性、单机构研究,分析了 2014 年至 2021 年间无远处转移疾病的 cT4 乳腺癌患者,这些患者行乳房切除术伴或不伴重建。作为常规护理,在术前、术后 6 个月、1 年和 2 年时使用 BREAST-Q 进行评估。比较乳房切除术无重建(NR)、即刻重建(IR)和延迟重建(DR)组之间的满意度和生活质量。
本研究共纳入 144 例符合条件的患者,71 例(49%)行 NR,36 例(25%)行 DR,37 例(26%)行 IR。行重建的患者年龄更小,更倾向于选择对侧预防性乳房切除术。重建时间与任何时间点的乳房满意度(SATBR)无显著差异。对于行 DR 的患者,重建后乳房满意度随时间增加。无论何时,IR、DR 和 NR 患者的胸部生理舒适度(PWB-CHEST)均无显著差异。行 DR 的患者 PWB-CHEST 评分从术前开始逐渐升高。行 IR 和 NR 的患者 PWB-CHEST 随时间逐渐下降。心理社会健康(PSWB)在不同时间点或亚组间无显著差异。
选择重建的 T4 乳腺癌患者,其基于重建时间的患者报告结局无显著差异。在 DR 队列中,重建后 SATBR 显著改善。这些数据有助于为面临 DR、IR 和 NR 选择的患者提供乳房重建决策依据。